LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Corrigendum: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis

Photo by naomish from unsplash

[This corrects the article DOI: 10.3389/fonc.2021.737767.]. Click to show full abstract

[This corrects the article DOI: 10.3389/fonc.2021.737767.].

Keywords: corrigendum real; lenvatinib versus; versus sorafenib; world lenvatinib; real world; sorafenib patients

Journal Title: Frontiers in Oncology
Year Published: 2021

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended


                Click one of the above tabs to view related content.